Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,203 trials

NCT07876154
Recruiting
Iparomlimab/Tuvonralimab Combined With Nab-paclitaxel and Cisplatin as Neoadjuvant Therapy for Locally Advanced Cervical Cancer
Phase 2 · China · 1 site
Registry update: 15 Oct 2026
NCT07072234
Recruiting
Phase I Study of Allogeneic Transforming Growth Factor-beta Receptor Type 2 Knockout CD70 CAR NK Cells in Treatment Refractory Clear Cell Renal Cell Carcinoma
Phase 1 · United States · 1 site
Registry update: 29 Apr 2026
2024-517538-16-00
Recruiting
TezeBarrier Study
Phase 4 · Austria · 1 site
Registry update: 3 Mar 2025
NCT07584161
Recruiting
MH-ART vs CF-IMRT in Postoperative Cervical/Endometrial Cancer
Not applicable · China · 1 site
Registry update: 16 Sept 2026
NCT07220096
Recruiting
Registry Trial and Needs Assessment of Patients With Young-onset Lung Cancer: Impact of a Dedicated Care Program on Patient Experience and Outcomes
Not applicable · United States · 1 site
Registry update: 6 Oct 2026
NCT07160530
Recruiting
Healthy Children, Healthy Communities: Effectiveness of a Multilevel Rural Community Engagement Model for Improving Children's Dietary Intake in Family Child Care Homes
Not applicable · United States · 1 site
Registry update: 1 Sept 2026
NCT07275073
Recruiting
JMT106 Injection in the Treatment of Advanced Solid Tumors
Phase 1 · China · 1 site
Registry update: 18 Dec 2025
NCT07012798
Recruiting
FOLFOX Combined With Durvalumab (MEDI4736), Bevacizumab, and Stereotactic Body Radiotherapy in Sequential Treatment of Potentially Resectable Locally Advanced Hepatocellular Carcinoma
Phase 2 · China · 1 site
Registry update: 13 May 2026
NCT07117630
Recruiting
An Open-Label, Bayesian Adaptive Phase II Clinical Study in HR+/HER2- Advanced Breast Cancer After Progression on Standard Therapy
Phase 2 · China · 1 site
Registry update: 13 Jul 2026
NCT07836348
Recruiting
A Closed Unit Incorporating Soteria Elements Versus a Conventional Closed Psychiatric Ward
Not applicable · Israel · 1 site
Registry update: 23 Sept 2026
NCT07188610
Recruiting
PA3-17 Injection in Adult Patients With CD7-positive Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma
Phase 2 · China · 16 sites
Registry update: 6 Jul 2026
NCT07830654
Recruiting
This Protocol is a Sub-study Under the PPMI Program. It is a Longitudinal, Single-center Study to Assess the Performance of [18F]AV-133 Imaging Using High and Standard Resolution PET in Individuals Enrolled With Parkinson's Disease (PD) for up to 12 Months.
Phase 2 · United States · 1 site
Registry update: 21 Sept 2026
NCT06960902
Recruiting
Study of the Determinants of Coronary Atherosclerosis in Familial Hypercholesterolemia (ATHERO-FH Study)
Not applicable · France · 9 sites
Registry update: 19 Mar 2026
NCT07351487
Recruiting
Neoadjuvant Chemotherapy Combined With Sintilimab and Bevacizumab for TNBC (NEOTORCH-BREAST07)
Phase 2 · China · 2 sites
Registry update: 20 Jan 2026
NCT07175922
Recruiting
Research Into the Expression of the csgA-gene and How it Changes in Patients With Parkinson's Disease
Not applicable · Netherlands · 1 site
Registry update: 19 Aug 2026
NCT06561074
Recruiting
A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy)
Phase 2 · United States · 1 site
Registry update: 18 Sept 2026
NCT06123156
Recruiting
Interest of Early Erectile Rehabilitation With Sildenafil After Radiotherapy and Proctectomy for Rectal Cancer
Phase 3 · France · 14 sites
Registry update: 12 May 2026
NCT07180160
Recruiting
Iparomlimab and Tuvonralimab (QL1706) in Patients With HR-positive, HER2-negative Advanced Breast Cancer
Phase 2 · China · 1 site
Registry update: 18 Nov 2025
NCT07173270
Recruiting
Improved Oral Health in Head and Neck Cancer Survivors
Not applicable · Sweden · 1 site
Registry update: 3 Sept 2026
NCT07312630
Recruiting
Clinical Study of LV009 Injection for the Treatment of Relapsed/Refractory CD19-Positive Hematologic and Lymphoid Malignancies
Early phase 1 · China · 1 site
Registry update: 31 Dec 2025

Ordered by registry start date. Freshness and sponsorship never change the order.